Maxcyte (MXCT) Work In Process (2023 - 2026)
Maxcyte (MXCT) reported Work In Process of $642000.0 for Q1 2026, up 222.61% year-over-year from $199000.0 in Q1 2025, and up 28.14% on a QoQ basis from $501000.0 in Q4 2025.
Maxcyte (MXCT) has 4 years of Work In Process data on file, last reported at $642000.0 in Q1 2026.
- Quarterly Work In Process rose 222.61% year-over-year to $642000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $642000.0 (up 222.61% YoY) and the FY2025 annual result came in at $501000.0, up 85.56% from the prior year.
- Work In Process climbed to $642000.0 in Q1 2026 per MXCT's latest filing, from $501000.0 in the prior quarter.
- Across five years, Work In Process topped out at $1.0 million in Q2 2023 and bottomed at $101000.0 in Q2 2024.
- The 4-year median for Work In Process is $400000.0 (2025), against an average of $460169.2.
- The widest annual swing landed in 2024, when Work In Process plunged 89.93%; it then soared 233.66% in 2025.
- Tracing MXCT's Work In Process over 4 years: stood at $558000.0 in 2023, then tumbled by 51.61% to $270000.0 in 2024, then surged by 85.56% to $501000.0 in 2025, then grew by 28.14% to $642000.0 in 2026.
- Per Business Quant, the three latest MXCT Work In Process figures stand at $642000.0 (Q1 2026), $501000.0 (Q4 2025), and $400000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 642,000.00 |
| Dec 31, 2025 | 501,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 337,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 305,000.00 |
| Jun 30, 2024 | 101,000.00 |
| Mar 31, 2024 | 301,000.00 |
| Dec 31, 2023 | 558,000.00 |
| Sep 30, 2023 | 694,000.00 |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 671,000.00 |